Adma Biologics (ADMA) Net Income towards Common Stockholders (2011 - 2026)
Adma Biologics (ADMA) reported Net Income towards Common Stockholders of $49.88 million for Q3 2026, up 36.9% from $36.43 million a year earlier and up 31.9% from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Net Income towards Common Stockholders (2011 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Adma Biologics' Net Income towards Common Stockholders came in at $182.41 million, down 12.9% year-over-year; for FY2025, it was $146.93 million, down 25.7% from FY2024.
- By year, Net Income towards Common Stockholders came in at $197.67 million in FY2024, -$28.24 million in FY2023, -$65.9 million in FY2022 and -$71.65 million in FY2021.
- The Q3 2026 figure ranks as the highest quarterly Net Income towards Common Stockholders since Q4 2024.
- Year over year, Net Income towards Common Stockholders has now increased in each of the last three quarters, with growth averaging 17.0% over the last seven quarters.
- Per Business Quant data, the three quarters before Q3 2026 came in at $37.82 million (Q2 2026), $45.33 million (Q1 2026) and $49.38 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 3.24 Bn |
| 10 | Adma Biologics | 2.87 Bn | 2.39 Bn | 99.92 Mn | 49.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 49.88 Mn |
| Jun 30, 2026 | 37.82 Mn |
| Mar 31, 2026 | 45.33 Mn |
| Dec 31, 2025 | 49.38 Mn |
| Sep 30, 2025 | 36.43 Mn |
| Jun 30, 2025 | 34.22 Mn |
| Mar 31, 2025 | 26.90 Mn |
| Dec 31, 2024 | 111.90 Mn |
| Sep 30, 2024 | 35.91 Mn |
| Jun 30, 2024 | 32.06 Mn |
| Mar 31, 2024 | 17.81 Mn |
| Dec 31, 2023 | -17.65 Mn |
| Sep 30, 2023 | 2.57 Mn |
| Jun 30, 2023 | -6.37 Mn |
| Mar 31, 2023 | -6.79 Mn |
| Dec 31, 2022 | -12.23 Mn |
| Sep 30, 2022 | -14.90 Mn |
| Jun 30, 2022 | -13.76 Mn |
| Mar 31, 2022 | -25.01 Mn |
| Dec 31, 2021 | -16.65 Mn |
API Access
Adma Biologics Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();